Nature Cancer, Published online: 25 August 2026; doi:10.1038/s43018-026-01221-3Chen and colleagues report that the neuropeptide galanin impairs antitumor immunity in glioblastoma by interacting with its receptor GALR3 on monocytic myeloid-derived suppressor cells, promoting their infiltration and ferroptosis resistance.